Health Care Professional Information
Essiac, Vitaltea®, Flor-Essence®
- Cancer treatment
- Health maintenance
- HIV and AIDS
Mechanism of Action
Rhubarb and sheep sorrel contain anthraquinones that stimulate secretion of mucosa and water, as well as stimulate peristalsis. Additional activities of anthraquinones isolated from rhubarb show stimulation of IL-1, IL-6, and TNF in vitro and tumor necrosis against sarcoma 37, breast cancer, and Ehrlich cell lines in mice. Burdock root can induce hypoglycemia in animal models. Tannin extract may induce macrophage response and the lignan and sesquiterpene extracts were shown to inhibit platelet activating factor (PAF) in vitro (1) (2). Essiac was also shown to inhibit cytochrome P450 (CYP450) enzymes in vitro (6).
- Theoretically, patients with renal or hepatic insufficiency should not consume this product.
- Case Report: A 59-year-old woman reported symptoms of anorexia, nausea, myalgia, fatigue, and generalized abdominal pain following consumption of Essiac tea for six months. Her symptoms resolved after discontinuing the tea (13).
- The manufacturer of Flor Essence states that users may experience increased bowel movements, frequent urination, swollen glands, skin blemishes, flu-like symptoms, or slight headaches (14).
Cytochrome P450: Decreased clearance of an experimental chemotherapy drug was reported in a patient taking Essiac (4). This may be due to inhibition of cytochrome P450 enzymes by Essiac (6).
Dosage (Inside MSKCC Only)
This field is only visible to only OneMSK users.
- Tamayo C, et al. The chemistry and biological activity of herbs used in Flor-essence herbal tonic and Essiac. Phytotherapy Res 2000;14:1-14.
- Locock RA. Essiac. Can Pharm J 1997;130:18-19,51.
- Kulp KS, Montgomery JL, Nelson DO, et al. Essiac and Flor-Essence herbal tonics stimulate the in vitro growth of human breast cancer cells. Breast Cancer Research and Treatment 2006; 98:249-259.
- Geyer C, et al. Dose-schedule optimization the hexacyclic camptothecin (CPT) analog dx-8951f: a phase I and pharmacokinetic study with escalation of both treatment duration and dose (meeting abstract). Proc Annu Meet Am Soc Clin Oncol. 1999;18.
- Kaegi E. Unconventional therapies for cancer: 1. Essiac. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. CMAJ 1998;158:897-902.
- Seely D, Kenney DA, Myers SP, et al. In vitro analysis of the herbal compound Essiac. Anticancer Res 2007;27(6B):3875-82.
- Ottenweller J, Putt K, Blumenthal EJ, et al. Inhibition of prostate cancer-cell proliferation by Essiac. J Altern Complement Med 2004 Aug;10(4):687-91.
- Eberding A, Madera C, Xie S, et al. Evaluation of the antiproliferative effects of Essiac on in vitro and in vivo models of prostate cancer compared to paclitaxel. Nutr Cancer 2007;58(2):188-96.
- Al-Sukhni W, Grunbaum A, Fleshner N. Remission of hormone-refractory prostate cancer attributed to Essiac. Can J Urol 2005;12(5):2841-2.
- Zick SM, Sen A, Feng Y, et al. Trial of Essiac to ascertain its effect in women with breast cancer (TEA-BC). J Altern Complement Med 2006 Dec;12(10):971-80.
- Taj J, Cheung S, Wong S, Lowe C. In vitro comparison of Essiac and Flor-Essence on human tumor cell lines. Oncol Rep 2004 Feb;11(2):471-6.
- Leonard SS, Keil D, Mehlman T, et al. Essiac tea: Scavenging of reactive oxygen species and effects on DNA damage. J Ethnopharmacol 2006 ;103(2):288-96.
- Kessenich CR, Higgs D. Herbal tea components and liver function. Nurse Pract. 2010 Aug;35(8):10-1.
- Flora Flor*Essence®. Burnaby, Canada: Flora Manufacturing & Distributing Ltd. http://www.florahealth.com/product_categories.cfm. Accessed May 31, 2012.
How It Works
Bottom Line: Essiac has not been shown to treat or prevent cancer.
Essiac was developed in the 1920s by Rene Caisse, a Canadian nurse. It contains four botanicals: burdock root, sheep sorrel, slippery elm, and rhubarb. Laboratory studies have shown that Essiac has antioxidant and cytotoxic properties. But results are conflicting on Essiac's antiproliferative effects. Essiac prevented growth of prostate cancer cells but stimulated growth of breast cancer cells. In a study of breast cancer patients, Essiac did not improve quality of life or mood.
Despite unsubstantiated claims, Essiac remains a popular anticancer therapy today. Patients should avoid use of Essiac as it may delay conventional care.
- To treat cancer
Laboratory studies showed conflicting results. An observational study of breast cancer patients did not find any improvement in quality of life with Essiac.
- To treat HIV and AIDS
There is no clinical evidence to support this use.
- To stimulate the immune system
In laboratory studies, rhubarb, an ingredient of Essiac, suppressed activity of part of the immune system. Human studies are lacking.
- As a tonic
There are no clinical data to back this claim.
Do Not Take If
- You have kidney or liver problems.
- You are undergoing chemotherapy (in a case report, levels of a chemotherapy drug were increased in the blood of a patient also taking Essiac, with the potential for increased toxicity.)
- Case Report: A 59-year-old woman reported symptoms of anorexia, nausea, myalgia, fatigue, and generalized abdominal pain following consumption of Essiac tea for six months. Her symptoms resolved after discontinuing the tea.
- The manufacturer of Flor Essence states that users may experience increased bowel movements, frequent urination, swollen glands, skin blemishes, flu-like symptoms, or slight headaches.
Last updated: September 27, 2012